Showing results (51-60 of 128) with videos related to
Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|July 13, 2016
Molecular Epidemiology of a Vancomycin-Intermediate Heteroresistant Staphylococcus epidermidis Outbreak in a Neonatal Intensive Care UnitJasmine Chong, Caroline Quach, Ana C Blanchard, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoringDaniel E Speiser, Mikaël J Pittet, Philippe Guillaume, et al.The Journal of Biological Chemistry|September 7, 2002
CD3 delta establishes a functional link between the T cell receptor and CD8Marie-Agnès Doucey, Laurence Goffin, Dieter Naeher, et al.European Journal of Immunology|March 1, 2002
In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cellsDaniel E Speiser, Danielle Liénard, Mikaël J Pittet, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2018
The Length Distribution and Multiple Specificity of Naturally Presented HLA-I LigandsDavid Gfeller, Philippe Guillaume, Justine Michaux, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
TCR-alpha CDR3 loop audition regulates positive selectionCristina Ferreira, Anna Furmanski, Maggie Millrain, et al.Molecular & Cellular Proteomics : MCP|December 19, 2019
Mass Spectrometry Based Immunopeptidomics Leads to Robust Predictions of Phosphorylated HLA Class I LigandsMarthe Solleder, Philippe Guillaume, Julien Racle, et al.Vaccine|December 30, 2008
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challengeJackeline F Romero, Annalisa Ciabattini, Philippe Guillaume, et al.Cell Systems|January 5, 2023
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopesDavid Gfeller, Julien Schmidt, Giancarlo Croce, et al.Cancer Immunology, Immunotherapy : CII|June 15, 2007
Low TCR avidity and lack of tumor cell recognition in CD8(+) T cells primed with the CEA-analogue CAP1-6D peptideManuela Iero, Paola Squarcina, Pedro Romero, et al.Pageof 13